SCHEMBL6360374

SCHEMBL6360374

CN(CCc1ccccn1)S(=O)(=O)c1ccc(C(=O)Nc2ccc(Br)cc2C(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
KDM4E B2RXH2 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
POLB P06746 1/20 0.48
GAA P10253 4/20 0.46
KMT2A Q03164 1/20 0.46
AKR1C2 P52895 3/20 0.45
AKR1C1 Q04828 3/20 0.45
LMNA P02545 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PKM P14618 1/20 0.44
SLC12A2 P55011 1/20 0.44
SLC12A5 Q9H2X9 1/20 0.44
AKR1C4 P17516 1/20 0.44
AKR1C3 P42330 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6347763 0.83 POLB (0.52) MAPTPOLBGAAKMT2AAKR1C2
SCHEMBL6352584 0.79 APEX1 (0.48) MAPTKDM4ESMN1; SMN2POLBKMT2A
SCHEMBL6352951 0.79 AKR1C2 (0.57) MAPTSMN1; SMN2KMT2AAKR1C2AKR1C1
SCHEMBL6352378 0.79 MEN1 (0.61) MAPTKDM4EPOLBGAAKMT2A
SCHEMBL6350795 0.78 DNMT3A (0.49) MAPTKMT2AAKR1C2AKR1C1NPSR1
SCHEMBL6347821 0.76 APEX1 (0.58) MAPTSMN1; SMN2GAAKMT2AAKR1C2
SCHEMBL6353021 0.76 MEN1 (0.55) MAPTKDM4ESMN1; SMN2POLBKMT2A
SCHEMBL6350782 0.74 AKR1C2 (0.51) MAPTGAAKMT2AAKR1C2AKR1C1
SCHEMBL6359090 0.74 ALB (0.53) KDM4ESMN1; SMN2KMT2ALMNAALDH1A1
SCHEMBL6352622 0.73 KCNK2 (0.59) MAPTKMT2AAKR1C2AKR1C1AKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 MAPT 4753/4885KDM4E 2637/4885SMN1; SMN2 3015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.